Prolocor
Latest round
- Seed
Last raised
- Aug 2022
Total raised
- $3.2M
Investors
- 2
About Prolocor
Founded in 2020 by David Schneider, and Peter M. DiBattiste (CEO), and based in Philadelphia, US, Prolocor Inc. is a healthcare startup that is a diagnostic test developer that uses FcyRIIa platelets to predict an individual's risk of thrombosis. In August 2022, Prolocor Inc. The company provides a precision diagnostic test based on platelet FcRIIa on the surface of platelets, which guides doctors in treatment decisions by matching the intensity of therapy with the risk of events in acute coronary syndrome to prevent thrombosis.
Who invested in Prolocor
2 investors across 1 round
See all investors in Prolocor
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 16, 2022
Amount
$3.2M
Investors
Questions about Prolocor
Who invested in Prolocor?
Prolocor has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prolocor raised?
Prolocor has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Prolocor last raise money?
Prolocor's most recent round on record is a Seed, in Aug 2022.
What does Prolocor do?
Founded in 2020 by David Schneider, and Peter M.
Where is Prolocor headquartered?
Prolocor is headquartered in Philadelphia, US.
Which VCs invest in companies like Prolocor?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Prolocor's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like Prolocor? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.